Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    Open Studies | "Sexual Dysfunction, Physiological"
Show Display Options
Rank Status Study
21 Recruiting Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: mesenchymal stem cell (Cellgram-ED)
22 Recruiting Low Energy Shockwave Therapy for Improving Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Pre-inclusion questionnaires;   Drug: 1 month of PDE5i treatment;   Other: PDE5i follow-up questionnaires;   Other: Inclusion questionnaires;   Device: 4 weekly LIESWT (Wave 1) with the RENOVA device;   Device: 4 weekly sham LIESWT (Wave 1) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 1;   Other: Follow-up questionnaires 3 months after Wave 1;   Device: 8 bi-weekly LIESWT (Wave 2) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 2;   Other: Questionnaires via postal mail;   Other: Final follow-up questionnaires 12 months after Wave 2
23 Recruiting Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Liposuction;   Biological: AD-SVF Cell Injection
24 Recruiting Management of Sexual Dysfunction With Bioresonance Technique
Conditions: Sexual Dysfunction;   Erectile Dysfunction;   Premature Ejaculation
Intervention:
25 Recruiting Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial
Condition: Erectile Dysfunction Following Radical Prostatectomy
Interventions: Biological: Radical prostatectomy with implantation of allograft;   Procedure: Radical prostatectomy without implantation of allograft
26 Recruiting Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate and No Erectile Dysfunction
Condition: Organic Erectile Dysfunction
Intervention: Device: Viberect
27 Recruiting Prevalence Of Internal Pudendal Artery Disease In Patients With Erectile Dysfunction Undergoing Diagnostic Coronary Angiography
Condition: To Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary Angiography
Intervention:
28 Recruiting The Early Diagnosis and Warning Role of Erectile Dysfunction
Conditions: Erectile Dysfunction;   Endothelial Dysfunction
Intervention:
29 Not yet recruiting Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule
Conditions: Menopause;   Dyspareunia
Intervention: Device: DESIRIAL® (Intra-mucosal Injections of Cross-linked Hyaluronic Acid)
30 Not yet recruiting Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health
Conditions: Dyspareunia;   Endometriosis
Intervention: Behavioral: Questionnaires
31 Recruiting Management of Peyronie's Disease With Adipose Tissue Stem Cell
Conditions: Erectile Dysfunction;   Peyronie' Disease
Intervention: Drug: Adipose tissue stem cell injection
32 Recruiting Effects of Sildenafil on Penile Vascular Function in Hypertensive Men With Erectile Dysfunction
Conditions: Arterial Hypertension;   Erectile Dysfunction
Interventions: Drug: sildenafil citrate;   Other: comparator group
33 Recruiting Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
Conditions: Sexual Dysfunctions, Psychological;   Hypoactive Sexual Desire Disorder;   Erectile Dysfunctions
Interventions: Drug: Bupropion hydrochloride sustained-release;   Drug: placebo
34 Recruiting the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males
Condition: Erectile Dysfunction
Intervention: Device: Rigiscan test
35 Recruiting Transperineal Ultrasound to Assess the Progress of Labour
Conditions: Placenta Praevia;   Vaginismus
Intervention:
36 Recruiting The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
Conditions: Benign Prostatic Hyperplasia;   Erectile Dysfunction
Interventions: Drug: Tamsulosin 0.2mg;   Drug: Tadalafil 5mg;   Drug: Placebo for Tamsulosin
37 Recruiting The Vaginal Health Trial
Conditions: Atrophy of Vagina;   Menopause;   Vaginal Discharge;   Dyspareunia (Female)
Interventions: Drug: Vagifem;   Drug: Replens;   Other: Placebo
38 Recruiting The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy
Conditions: Premature Ejaculation;   Erectile Dysfunction
Intervention: Drug: Dapoxetine/Sildenafil 30/50 mg film coated tablet
39 Recruiting Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain
Condition: Dyspareunia
Interventions: Procedure: Manual therapy;   Procedure: Trigger point dry needling
40 Recruiting Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Erectile Dysfunction
Interventions: Other: DE assessment;   Other: AGE measurement

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.